Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Accounts receivable, net of expected credit losses of $4,649 and $4,592, respectively
Contract assets
Deferred contract costs
Prepaid expenses and other current assets
Total current assets
Property and equipment, net of accumulated depreciation and amortization of $26,847 and $20,253, respectively
Intangible assets, net of accumulated amortization of $14,112 and $12,205, respectively
Goodwill
Contract assets, noncurrent
Deferred contract costs, noncurrent
Operating lease right-of-use assets
Long-term investments
Other assets, noncurrent
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Unearned revenue
Operating lease liabilities, current
Total current liabilities
Unearned revenue, noncurrent
Operating lease liabilities, noncurrent
Other liabilities, noncurrent
Total liabilities
Redeemable convertible preferred stock, $0.001 par value, zero and 60,509,120 shares authorized at December 31, 2021 and December 31, 2020, respectively; zero and 58,962,749 issued and outstanding at December 31, 2021 and December 31, 2020, respectively
Stockholders’ equity:
Class A common stock, $0.001 par value; 1,700,000,000 shares authorized at June 30, 2025 and December 31, 2024; 120,334,155 and 115,635,624 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively. Class B common stock, $0.001 par value; 185,000,000 shares authorized at June 30, 2025 and December 31, 2024; 48,653,295 and 50,307,240 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively
Preferred stock, $0.001 par value; 20,000,000 shares authorized at June 30, 2025 and December 31, 2024
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support